Recently Viewed
Clear All
Bidding Date
13-Nov-2024 to
18-Nov-2024
Issue Size
₹29.34 Cr
Price Band
₹58 to ₹61
Allotment date
19-Nov-2024
Listing date
22-Nov-2024
Lot size
2000
No. of shares
48,10,000
Fresh issue/OFS
₹29.34 Cr /--
Onyx Biotec is a pharmaceutical contract manufacturer specializing in sterile pharmaceutical products. The company started its operations in the pharmaceutical industry in 2010, initially with sterile water for injections. Over the years, Onyx expanded its product portfolio to include Dry Powder Injections and Dry Syrup for both domestic and international markets. Their core business is focused on providing end-to-end product development and manufacturing solutions, which includes the preparation and filing of regulatory dossiers for the Indian and global markets. The company supplies to major pharmaceutical companies across India and globally, including Hetero Healthcare, Mankind Pharma, Sun Pharmaceutical, Aristo Pharmaceuticals, and others. the company manufactures these products in two facilities in Himachal Pradesh, with modern equipment and sustainable practices in place.
Category
Status
QIBs
--
NIIs
--
Retail
--
Others
--
Total
183.9x
The issue size of Onyx Biotec Ltd is ₹29.34 Cr.
Onyx Biotec Ltd falls into Healthcare Devices & Equipment industry.
The Onyx Biotec Ltd IPO will be listed on BSE.
The open and close dates for the Onyx Biotec Ltd are 13-Nov-2024 & 18-Nov-2024.
The price band for the Onyx Biotec Ltd ipo is ₹58 to ₹61
The listing date of Onyx Biotec Ltd IPO is 22-Nov-2024.
The purpose of this IPO is to raise fresh capital.
Onyx Biotec Ltd total subscription ratio is 183.9X.
Key financial of the Onyx Biotec Ltd are:
Onyx Biotec Ltd | FY-24 | FY-23 | FY-22 |
---|---|---|---|
Revenue (₹ Cr) | 53.75 | 39.48 | 44.86 |
EBIT (₹ Cr) | 6.04 | 2.96 | 4.18 |
Proft after Tax (₹ Cr) | 3.03 | 1.84 | 3.35 |
Debt (₹ Cr) | 30.78 | 29.23 | 12.24 |
Net Worth (₹ Cr) | 24.88 | 18.2 | 16.38 |
RoE (%) | 12.18 | 10.11 | 20.45 |